knowledge -WSS

knowledge

author：focus 2025-09-06 04:15:14 - browse：119

Photograph of Bill Cassidy. -- health policy coverage from STAT — Sen. Bill Cassidy (R-La.) Kevin Dietsch/Getty Images

WASHINGTON — With Novo Nordisk’s Wegovy and Ozempic hitting blockbuster sales and a new rival approved this week, everyone in Washington is thinking about how to manage the crashing wave of weight loss drug costs.

The explosive national demand for weight management therapies and diabetes drugs like Ozempic — all of which are indicated for indefinite use — has become central in an ongoing policy debate over high drug costs and controversial tactics to manage them, including President Biden’s plan to let the government negotiate directly with pharmaceutical companies. Seventy percent of Americans could qualify for these medicines.

Sen. Bill Cassidy (R-La.), the highest-ranking Republican on the Senate’s health policy committee, has vehemently opposed the negotiation plan, arguing it reduces incentives to develop new therapies and may not actually reduce patients’ costs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Bill would stop addiction treatment from triggering child abuse inquiry

WSS

Boston's new lab space is opening empty

FDA advisers back CAR

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

First U.S. drug developed to treat liver disease MASH is approved

Ebola: Gilead Sciences antiviral shows promise as new treatment

Colorectal cancer study finds potential in overlooked immune cell

Wikipedia

knowledge

leisure time

How one medical school became remarkably diverse

Ebola: Gilead Sciences antiviral shows promise as new treatment

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Alkermes shareholders re

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Jerome Adams on the need for new antivirals for Covid

Why depression after traumatic brain injury is distinct

Anesthesiologist group: stop taking Ozempic before surgery

Sana to lay off nearly a third of staff, de

entertainment

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Bill would stop addiction treatment from triggering child abuse inquiry

Physician executives need more than on

Chan Zuckerberg Biohub Chicago to focus on inflammation

As AI in medicine takes off, can 'human in the loop' prevent harm?

leisure time

explore

hotspot

leisure time